The difference in fasting blood insulin levels that we found between the two groups could be linked to the greater reduction in peripheral free fatty acid over-secretion—as a results of FM reduction—in the ProMoFasT group through a negative stimulation of the hormone-sensitive lipase, whose overexpression is mediated by hyperinsulinism [39]. This evidence concerns the gene INS and hyperinsulinism.